Swedbank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Swedbank's ALNY Position: Q3 2026 in Review
Swedbank increased its Alnylam Pharmaceuticals (ALNY) stake by 6.1% in Q3 2026, buying an estimated $962K and bringing the position to 65,674 shares worth $16.2M. The position accounts for 0.01% of the portfolio, ranked #424.
Swedbank first reported a position in ALNY in Q1 2021 and has held it in 23 quarters since. The position peaked at $101M in Q4 2022. 726 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Swedbank held 65,674 shares of Alnylam Pharmaceuticals worth $16.2M as of Q3 2026.
- Swedbank bought 3,780 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $962K.
- Alnylam Pharmaceuticals made up 0.01% of Swedbank's portfolio in Q3 2026, its #424 holding.
- Swedbank first reported a position in Alnylam Pharmaceuticals in Q1 2021 and has held it in 23 quarters since.
- Swedbank's Alnylam Pharmaceuticals position peaked at $101M in Q4 2022.
- 726 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.